Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France

This cohort study assesses the incidence and severity of COVID-19 among vaccinated recipients of allogenic stem cell transplant in a single center after 1 or 2 messenger RNA booster doses during the Omicron wave in France.

Domaines

Sciences du Vivant [q-bio]

Bibliothèque universitaire Nantes Université : Connectez-vous pour contacter le contributeur

https://nantes-universite.hal.science/hal-04743269

Soumis le : vendredi 18 octobre 2024-11:31:00

Dernière modification le : dimanche 20 octobre 2024-03:14:17

Dates et versions

hal-04743269 , version 1 (18-10-2024)

Identifiants

HAL Id : hal-04743269 , version 1
DOI : 10.1001/jamanetworkopen.2022.47534
PUBMED : 36534404
PUBMEDCENTRAL : PMC9856420

Citer

Valentin Letailleur, Amandine Le Bourgeois, Thierry Guillaume, Maxime Jullien, Marianne Coste-Burel, et al.. Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France. JAMA Network Open, 2022, 5 (12), pp.e2247534. ⟨10.1001/jamanetworkopen.2022.47534⟩. ⟨hal-04743269⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS UNIV-ANGERS CRCI2NA NANTES-UNIVERSITE UFR-MEDECINE-NANTES

3 Consultations

0 Téléchargements